Post-transplant glomerular diseases: update on pathophysiology, risk factors and management strategies
2024

Update on Post-Transplant Glomerular Diseases

Sample size: 11742 publication 10 minutes Evidence: moderate

Author Information

Author(s): Anna Regalia, Matteo Abinti, Carlo Maria Alfieri, Mariarosaria Campise, Simona Verdesca, Francesca Zanoni, Giuseppe Castellano

Primary Institution: Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Hypothesis

What are the recent advancements in the pathophysiology, risk factors, and management strategies for post-transplant glomerular diseases?

Conclusion

Post-transplant glomerular diseases are increasingly recognized as a leading cause of allograft loss, necessitating improved understanding and management strategies.

Supporting Evidence

  • Advancements in immunosuppressive medications have improved short-term graft survival.
  • Post-transplant glomerular diseases are now a leading cause of allograft loss.
  • Registry data indicate that primary glomerular diseases are frequent among kidney transplant recipients.

Takeaway

After getting a kidney transplant, some people can develop new kidney problems that weren't there before, which can make the transplant less successful.

Methodology

This review summarizes recent advancements in the understanding of post-transplant glomerular diseases, including their epidemiology, pathogenesis, predictors, and management strategies.

Limitations

The review is based on existing literature and may not encompass all recent findings or ongoing studies.

Digital Object Identifier (DOI)

10.1093/ckj/sfae320

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication